All In Biotech

Drug Trial Radar · NCT00261443

A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

Efficacy of Aripiprazole in Combination With Lithium or Valproate in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients Partially Nonresponsive to Lithium or Valproate Monotherapy

Last checked: Nov 19, 2026Latest source record: Apr 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,270 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,270

Actual

Start

Sep 2005

Primary completion

Jun 2009

Study completion Oct 2009

Sponsor

Sponsor type
Industry
First posted
Dec 5, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical research study is to learn if outpatients with bipolar mania who are partially nonresponsive to lithium or valproate monotherapy can achieve stable symptoms on a combination treatment of aripiprazole plus lithium or valproate.

Conditions

  • Bipolar Disorder

Interventions

  • Lithium or Valproate with placebo (PBO)Drug

    Tablets, Oral, once daily lithium 250-2100 mg/day valproate 250-2500mg/day Placebo once daily

  • Lithium or Valproate with AripiprazoleDrug

    Tablets, Oral, once daily, 52 weeks post randomization (Pre-Randomization Phases 13-24 weeks) lithium 250-2100 mg/day valproate 250-2500mg/day aripiprazole 15-30 mg/day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants Not Experiencing Relapse to Any Mood Episode Through Week 52, Phase 3Time frame: Week 0, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52 of Phase 3 (A 52-Week Assessment of Relapse Phase following Phase 2 [13 to 24 weeks] and Phase 1 [2 to 8 weeks])

Locations

83 sites in 9 countries. Site status is shown where the registry gives one.

  • Tuscaloosa Va Medical Center

    Tuscaloosa, Alabama

  • Pravin Kansagra, M.D.

    Anaheim, California

  • Psychopharmacology Research Network Of Torrance

    Cerritos, California

  • Atp Clinical Research, Inc.

    Costa Mesa, California

  • Us Clinical Research Centers, Llc

    Costa Mesa, California

  • Va Long Beach Healthcare System

    Long Beach, California

  • Synergy Clinical Research Center

    National City, California

  • University Of California, Irvine Medical Center

    Orange, California

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • University Of South Florida

    Tampa, Florida

  • Carman Research

    Smyrna, Georgia

  • University Of Massachusetts Medical School

    Worcester, Massachusetts

  • Psych Care Consultants Research

    St Louis, Missouri

  • Cns Research Institute, P.C.

    Clementon, New Jersey

  • Neuropsychiatric Research Associates

    New York, New York

  • Behavioral Medical Research Of Staten Island

    Staten Island, New York

  • Richmond Behavioral Associates

    Staten Island, New York

  • Psychiatry And Clinical Research

    Raleigh, North Carolina

  • Rakesh Ranjan, Md & Associates, Inc.

    Beachwood, Ohio

  • University Of Cincinnati Medical Center

    Cincinnati, Ohio

  • Metro Health Medical Center

    Cleveland, Ohio

  • Midwest Clinical Research Center

    Dayton, Ohio

  • Portland Va Medical Center

    Portland, Oregon

  • Senior Adults Specialty Research, Inc.

    Austin, Texas

  • Futuresearch Trials

    Dallas, Texas

  • Insite Clinical Research

    DeSoto, Texas

  • Red Oak Psychiatry Associates, Pa

    Houston, Texas

  • University Of Utah School Of Medicine

    Salt Lake City, Utah

  • Northwest Clinical Research Center

    Bellevue, Washington

  • Local Institution

    Rio de Janeiro, Brazil

  • Local Institution

    São Paulo, Brazil

  • Local Institution

    São Paulo, Brazil

  • Local Institution

    Salvador, Estado de Bahia, Brazil

  • Local Institution

    Aparecida de Goinia, Goiás, Brazil

  • Local Institution

    Pelotas, Rio Grande do Sul, Brazil

  • Local Institution

    Burgas, Bulgaria

  • Local Institution

    Rousse, Bulgaria

  • Local Institution

    Rijeka, Croatia

  • Local Institution

    Split, Croatia

  • Local Institution

    Zadar, Croatia

Showing 40 of 83 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.